Who Benefits the Most From Adjuvant Durvalumab After Chemoradiotherapy for Non-small Cell Lung Cancer? An Exploratory Analysis

Publication date: Available online 27 October 2020Source: Practical Radiation OncologyAuthor(s): Nitin Ohri, Balazs Halmos, William R. Bodner, Haiying Cheng, Madhur K. Garg, Rasim Gucalp, Chandan Guha
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research